Hajime Sakai
Fondateur chez Napigen, Inc.
Fortune : 688 123 $ au 31/05/2024
Profil
Hajime Sakai has founded Napigen, Inc. in 2016 and currently holds the titles of President, Chief Executive Officer & Director.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SHINTO PAINT CO., LTD.
1,07% | 30/09/2023 | 332 000 ( 1,07% ) | 266 201 $ | 31/05/2024 |
TOWNNEWS-SHA CO., LTD.
0,89% | 30/06/2023 | 49 500 ( 0,89% ) | 242 547 $ | 31/05/2024 |
| 31/12/2023 | 243 000 ( 1,30% ) | 179 375 $ | 31/05/2024 |
Postes actifs de Hajime Sakai
| Sociétés | Poste | Début |
|---|---|---|
Napigen, Inc.
 Napigen, Inc. Agricultural Commodities/MillingProcess Industries Napigen, Inc. is a biotechnology company that specializes in genome engineering of various organisms such as plants, microbes, and animals. The company is based in Wilmington, DE and Dr. Hajime Sakai has been the CEO since 2016. The company's technology targets mitochondria and chloroplasts, which are important for creating energy and producing biochemical molecules. The company's genome technology has broad applications in human and animal healthcare, agriculture, and industrial biotechnology. Napigen was founded in 2016 by a group of accomplished scientists, entrepreneurs, and investors including Dr. Hajime Sakai, Dr. Jay Keasling, Dr. Ganesh Kishore, and Dr. Roger Wyse. | Fondateur | 01/01/2016 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Napigen, Inc.
Napigen, Inc. Agricultural Commodities/MillingProcess Industries Napigen, Inc. is a biotechnology company that specializes in genome engineering of various organisms such as plants, microbes, and animals. The company is based in Wilmington, DE and Dr. Hajime Sakai has been the CEO since 2016. The company's technology targets mitochondria and chloroplasts, which are important for creating energy and producing biochemical molecules. The company's genome technology has broad applications in human and animal healthcare, agriculture, and industrial biotechnology. Napigen was founded in 2016 by a group of accomplished scientists, entrepreneurs, and investors including Dr. Hajime Sakai, Dr. Jay Keasling, Dr. Ganesh Kishore, and Dr. Roger Wyse. | Process Industries |
